---
title: "Kepler Capital  Reaffirms Their Buy Rating on Prudential (PRU)"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/284512527.md"
description: "Kepler Capital analyst Fahad Changazi maintained a Buy rating on Prudential on April 27 and set a price target of p1,326.48.Claim 55% Off TipRanksUnlock hedge fund-level data and powerful investing tools for smarter, sharper decisions Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks According to TipRanks, Changazi is ranked #5345 out of 12158 analysts. In a report released yesterday, Barclays also reiterated a Buy rating on the stock with a £14.00 price target."
datetime: "2026-04-29T07:16:50.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/284512527.md)
  - [en](https://longbridge.com/en/news/284512527.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/284512527.md)
---

# Kepler Capital  Reaffirms Their Buy Rating on Prudential (PRU)

Kepler Capital analyst Fahad Changazi maintained a Buy rating on Prudential on April 27 and set a price target of p1,326.48.

### Claim 55% Off TipRanks

-   Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
-   Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks

According to TipRanks, Changazi is ranked #5345 out of 12158 analysts.

In a report released yesterday, Barclays also reiterated a Buy rating on the stock with a £14.00 price target.

### Related Stocks

- [02378.HK](https://longbridge.com/en/quote/02378.HK.md)
- [PUK.US](https://longbridge.com/en/quote/PUK.US.md)
- [PRU.UK](https://longbridge.com/en/quote/PRU.UK.md)
- [K6S.SG](https://longbridge.com/en/quote/K6S.SG.md)
- [BARC.UK](https://longbridge.com/en/quote/BARC.UK.md)
- [BCS.US](https://longbridge.com/en/quote/BCS.US.md)

## Related News & Research

- [BREAKINGVIEWS-Pru India fix dials up risk — and potential reward](https://longbridge.com/en/news/286716447.md)
- [Prudential faces tough road in reviving Bharti AXA Life Insurance biz](https://longbridge.com/en/news/286786329.md)
- [Analyst Reiterates Buy on Dermata, Keeps 12-Month Price Target Unchanged at $4](https://longbridge.com/en/news/286958909.md)
- [LifeSci Capital Sticks to Their Buy Rating for Olema Pharmaceuticals (OLMA)](https://longbridge.com/en/news/286679129.md)
- [Why This Analyst Thinks Texas Instruments Stock Is on the Path to $1 Trillion](https://longbridge.com/en/news/286957345.md)